Wang D - Search Results

1

Preserving Macroporosity in Type III Porous Liquids.

Dai D, Luo L, Zhu Q, Wang D, Li T. Dai D, et al. Among authors: wang d. Angew Chem Int Ed Engl. 2023 Jun 19;62(25):e202303102. doi: 10.1002/anie.202303102. Epub 2023 May 9. Angew Chem Int Ed Engl. 2023. PMID: 37071477

2

Surface-Seal Encapsulation of a Homogeneous Catalyst in a Mesoporous Metal-Organic Framework.

Wang D, Li S, Wu C, Li T. Wang D, et al. J Am Chem Soc. 2022 Jan 19;144(2):685-689. doi: 10.1021/jacs.1c11573. Epub 2022 Jan 7. J Am Chem Soc. 2022. PMID: 34994193

3

Exploration of Hierarchical Metal-Organic Framework as Ultralight, High-Strength Mechanical Metamaterials.

Xing Y, Luo L, Li Y, Wang D, Hu D, Li T, Zhang H. Xing Y, et al. Among authors: wang d. J Am Chem Soc. 2022 Mar 16;144(10):4393-4402. doi: 10.1021/jacs.1c11136. Epub 2022 Mar 1. J Am Chem Soc. 2022. PMID: 35230831

4

A robust hollow metal-organic framework with enhanced diffusion for size selective catalysis.

Wu C, Zhao X, Wang D, Si X, Li T. Wu C, et al. Among authors: wang d. Chem Sci. 2022 Oct 24;13(45):13338-13346. doi: 10.1039/d2sc02838g. eCollection 2022 Nov 23. Chem Sci. 2022. PMID: 36507163 Free PMC article.

5

Toward MOF@Polymer Core-Shell Particles: Design Principles and Potential Applications.

Wang D, Li T. Wang D, et al. Acc Chem Res. 2023 Feb 21;56(4):462-474. doi: 10.1021/acs.accounts.2c00695. Epub 2023 Feb 6. Acc Chem Res. 2023. PMID: 36745822

6

Letter to the Editor: Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis.

Liu H, Li H, Wang DX, Li T. Liu H, et al. Hepatology. 2024 May 1;79(5):E144-E145. doi: 10.1097/HEP.0000000000000718. Epub 2023 Dec 13. Hepatology. 2024. PMID: 38090955 No abstract available.

7

Preserving Mesoporosity in Type III Porous Liquids through Dual-layer Surface Weaving.

Li S, Wang D, Lee Y, Li T. Li S, et al. Among authors: wang d. Angew Chem Int Ed Engl. 2024 Jun 10;63(24):e202405288. doi: 10.1002/anie.202405288. Epub 2024 May 3. Angew Chem Int Ed Engl. 2024. PMID: 38588044

8

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis.

Tian JC, Liu H, Yan LJ, Ding ZN, Han CL, Tian BW, Tan SY, Dong ZR, Wang DX, Xue JS, Mao XC, Yan YC, Li T. Tian JC, et al. Clin Exp Med. 2023 Oct;23(6):2115-2129. doi: 10.1007/s10238-022-00938-6. Epub 2022 Nov 16. Clin Exp Med. 2023. PMID: 36385419

9

Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.

Tian BW, Yan LJ, Ding ZN, Liu H, Han CL, Meng GX, Xue JS, Dong ZR, Yan YC, Hong JG, Chen ZQ, Wang DX, Li T. Tian BW, et al. Int Immunopharmacol. 2023 Jan;114:109519. doi: 10.1016/j.intimp.2022.109519. Epub 2022 Nov 30. Int Immunopharmacol. 2023. PMID: 36459922 Review.

10

Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis.

Tian BW, Yang YF, Yang CC, Yan LJ, Ding ZN, Liu H, Xue JS, Dong ZR, Chen ZQ, Hong JG, Wang DX, Han CL, Mao XC, Li T. Tian BW, et al. Immunotherapy. 2022 Dec;14(18):1481-1496. doi: 10.2217/imt-2022-0133. Epub 2022 Dec 20. Immunotherapy. 2022. PMID: 36537255 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,699 results

Search Page

Filters